 |
|
|||||
|
||||||
        |
||||||
|
|
 |
|||||
|
|
|
|
|||
|
|
|||||
| Momenta Pharmaceuticals
to Present at the MBC Mass Opportunities Biotechnology Investment Conference |
||||||
| CAMBRIDGE, MA — October 19,
2005 – Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology
company developing drugs based on its proprietary sugar sequencing technology,
announced today that Richard P. Shea, Vice President and Chief Financial
Officer, will present at the C.E. Unterberg, Towbin Emerging Growth Life
Sciences Conference on Wednesday, October 26, 2005 at 4:40 pm EDT at the
Palace Hotel New York, NY. A live audio webcast of the presentation will
be available on the “Investors” section of the Company’s
website located at www.momentapharma.com. A replay of the presentation
will be posted on the Momenta website approximately thirty minutes after
the event and will be available through November 26, 2005. About
Momenta: To receive additional information about Momenta, please visit our website at www.momentapharma.com, which does not form a part of this press release. Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners. Contact:
|
|
|||||
|
|
|
||||
|
|
|
|
|||
